Whether one has long-term immunity to COVID-19 after recovering from the virus is unclear amid a lack of scientific evidence. Still, antibodies might be the key to develop a vaccine and prevent virus reinfection.
Two Northwest Arkansas companies have developed tests to detect the presence of virus antibodies. Fayetteville-based Namida Lab Inc. has offered antibody, or serology, tests since May. Springdale-based NOWDiagnostics Inc. has developed a 15-minute antibody test approved for clinical use in Europe while awaiting emergency use approval from the U.S. Food and Drug Administration.
Interested in learning more? Read full article here.
NOWDiagnostics, Inc., based in Springdale, Arkansas, is a leader in innovative diagnostics testing. Its ADEXUSDx® product line features a lab at your fingertip, using a single drop of blood to test for a variety of common conditions, illnesses, and diseases, with results in a matter of minutes. By eliminating the need to send tests to off-site laboratories, NOWDiagnostics products have the potential to decrease the waiting period to determine test results by days. For more information about NOWDiagnostics, visit www.nowdx.com. For more information about the ADEXUSDx® COVID-19 Test, including its intended use, features, benefits and limitations, and directions for use, visit www.c19development.com. The ADEXUSDx® COVID-19 Test will be distributed by C19 Development, LLC, a wholly owned subsidiary of NOWDiagnostics. Laboratories may contact www.c19development.com/order to place an order.
Contacts
NOWDiagnostics Company Contact
Beth Cobb, Director of Operations
Email: [email protected]
NOWDiagnostics Media Contact
Claire Burghoff, CGA Group
Email: [email protected]